These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13904049)

  • 1. [Treatment of coronary circulatory disorders in internal practice with segontin].
    HAMANN E
    Landarzt; 1961 Nov; 37():1277-9. PubMed ID: 13904049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with segontin in internal medical practice].
    MENZEL M
    Ther Ggw; 1960 Sep; 99():432-4. PubMed ID: 13769511
    [No Abstract]   [Full Text] [Related]  

  • 3. [A double-blind experiment with the coronary therapeutic agent segontin].
    OVERKAMP H
    Med Klin; 1960 Aug; 55():1423-6. PubMed ID: 14429518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with the clinical use of Segontin in coronary disease].
    OHIRA I; HAGIWARA M; UMEZONO T; TSUCHIYA T; IMAGAWA S; MATSUOKA K
    Chiryo; 1962 Aug; 44():1573-7. PubMed ID: 14481363
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with segontin].
    RATSCHOW M; SCHOOP W
    Med Klin; 1960 Aug; 55():1421-3. PubMed ID: 14436429
    [No Abstract]   [Full Text] [Related]  

  • 6. [3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
    DELLA PORTA P; LUCCHINI CR
    Minerva Cardioangiol; 1961 Sep; 9():533-6. PubMed ID: 13885183
    [No Abstract]   [Full Text] [Related]  

  • 7. [On new possibilities in the therapy of coronary circulation disorders].
    LAUENROTH G
    Bull Off Chambre Synd Med Seine; 1960 Aug; 55():1434-5. PubMed ID: 13759428
    [No Abstract]   [Full Text] [Related]  

  • 8. [A contribution to the therapy of coronary circulatory disorders].
    BAMBOR HJ
    Med Klin; 1960 Jun; 55():1155-61. PubMed ID: 13796348
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical effects of a new anti-anginal agent, prenylamine ("Segontin").
    BAUMGARTEN A
    Med J Aust; 1962 Mar; 49(1)():429-31. PubMed ID: 13865947
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of a pyrimido-pyrimidine derivative as coronary vasodilator in clinical practice].
    BENITO SENDIN M; ALVAREZ SANCHEZ E
    Medicina (Madr); 1961 Oct; 29():469-82. PubMed ID: 13867248
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of coronary infarct with high doses of 1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline hydrochloride as well as the use of vasodilator substances in acute coronary occlusion].
    VOELKER R
    Arzneimittelforschung; 1962 Mar; 12():299-302. PubMed ID: 13926394
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical results with a new coronary dilatator agent: persantin].
    MARTINEZ RAMON E; ALCALA LLORENTE E
    Med Esp; 1961 Jun; 45():470-87. PubMed ID: 13767501
    [No Abstract]   [Full Text] [Related]  

  • 13. [Observations on a new synthetic coronary vasodilator].
    TRALDI A; TINCANI GP
    Minerva Med; 1962 Jun; 53():1747-50. PubMed ID: 13922271
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with segontin with special reference to chronic pulmonary heart disease, intrapleural pneumothorax and pneumoperitoneum].
    KOLLOTZEK H
    Med Welt; 1961 Nov; 44():2305-7. PubMed ID: 14458041
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the therapy of coronary insufficiency].
    DUETSCH L
    Ther Ggw; 1960 May; 99():228-34. PubMed ID: 13818454
    [No Abstract]   [Full Text] [Related]  

  • 16. [Criteria of the efficacy of the treatment of coronary disease: "the coronary vasodilators"].
    CLOAREC M
    Sem Hop Ther Paris; 1961 Oct; 37():753-4. PubMed ID: 13879970
    [No Abstract]   [Full Text] [Related]  

  • 17. [A contribution to the therapy of coronary insufficiency].
    LEIMGARDT H
    Medizinische; 1959 Dec; No 49():2408-12. PubMed ID: 14415455
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of coronary insufficiency with Persantin].
    RIEGLER E
    Wien Z Inn Med; 1961 Mar; 42():140-2. PubMed ID: 13741533
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary results in the treatment of coronary disease with segotonin].
    NEDELJKOVIC S; DORDEVIC BS
    Med Glas; 1961; 15():400-2. PubMed ID: 14478728
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study of a synthetic coronary vasodilator, L 2329].
    JORIS H; SCHMETZ J
    Rev Med Liege; 1961 Sep; 16():486-9. PubMed ID: 13790720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.